PROGRESSIVE MULTIPLE SCLEROSIS
Clinical trials for PROGRESSIVE MULTIPLE SCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new PROGRESSIVE MULTIPLE SCLEROSIS trials appear
Sign up with your email to follow new studies for PROGRESSIVE MULTIPLE SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cell therapy YTB323 tested in progressive MS patients
Disease control Recruiting nowThis early-phase trial tests a new treatment called YTB323 in 28 adults with non-active progressive multiple sclerosis (MS). The goal is to check if the therapy is safe and to see how it affects disability and disease progression. Participants receive a single dose, and researche…
Matched conditions: PROGRESSIVE MULTIPLE SCLEROSIS
Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 00:45 UTC
-
New drug combo aims to slow disability in progressive MS
Disease control Recruiting nowThis study tests whether adding a new drug (RO7268489) to the standard MS treatment ocrelizumab can slow disability progression in adults with progressive multiple sclerosis. About 360 participants will receive either the new drug or a placebo, and researchers will track walking …
Matched conditions: PROGRESSIVE MULTIPLE SCLEROSIS
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Experimental cell therapy takes on Tough-to-Treat MS
Disease control Recruiting nowThis early-stage study tests whether a new cell therapy called obe-cel is safe for people with progressive multiple sclerosis (MS) that hasn't responded to other treatments. About 18 adults will receive chemotherapy followed by a single infusion of obe-cel, then be closely monito…
Matched conditions: PROGRESSIVE MULTIPLE SCLEROSIS
Phase: PHASE1 • Sponsor: Autolus Limited • Aim: Disease control
Last updated May 15, 2026 11:52 UTC
-
Can a VR forest lift your mood? new study tests nature walks for MS depression
Symptom relief Recruiting nowThis study explores whether using a virtual reality headset to experience nature scenes can help reduce depression in people with progressive multiple sclerosis. Forty participants will use the Apple Vision Pro at home for short sessions over eight weeks. The goal is to see if th…
Matched conditions: PROGRESSIVE MULTIPLE SCLEROSIS
Phase: NA • Sponsor: University of Michigan • Aim: Symptom relief
Last updated May 17, 2026 00:47 UTC